Press Releases

March 8, 2023

KOL Event on Next-Generation Neurotherapeutics: Leveraging the Power of Music and Technology

January 31, 2023

MedRhythms’ Feasibility Study Shows Positive Topline Results in Parkinson’s Disease

January 17, 2023

MedRhythms Announces Positive Topline Results from Pivotal Trial in Chronic Stroke

December 7, 2022

MedRhythms Recognized for Advancements in Prescription Digital Therapeutics from CB Insights, Reuters Events Pharma and Fast Company

November 17, 2022

MedRhythms is a Fast Company Next Big Things in Tech Honoree

May 5, 2022

Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis

January 18, 2022

Digital Therapeutics Alliance Appoints MedRhythms Co-Founder Owen McCarthy to Chair Board of Directors

December 9, 2021

MedRhythms Named to the 2021 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups

November 16, 2021

MedRhythms Announces Addition of Global Brain Corporation and Bose Ventures to Series B Round